Neuropathy
NeurogesX Receives European Commission Approval for Qutenza(TM)
Published in Lab Law Weekly, June 5th, 2009
NeurogesX, Inc. (NASDAQ:NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, announced that the European Commission has formally granted marketing authorization of Qutenza(TM) 179 mg cutaneous patch (formerly NGX-4010) for the treatment of peripheral neuropathic pain in non-diabetic adults either alone or in combination with other medicinal products for pain. Qutenza can only be obtained with a prescription. The centralized marketing authorization allows Qutenza to be marketed in all 27 countries of the European Union.
The approval of Qutenza follows a positive opinion recommending approval from the European...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
Source: Lab Law Weekly (2009-06-05)
More Articles from Lab Law Weekly
- Acacia Research Corporation
Acacia Research Subsidiary, Creative Internet Advertising Corporation, Receives Jury Verdict Awarding $6.6 Million in Patent Infringement Case - Allied Security Innovations, Inc.
Allied Security Innovations Publishes Promising Financial Information - AmberPoint, Inc.
AmberPoint Delivers More Comprehensive Governance Capabilities for Heterogeneous Environments that Include SAP NetWeaverŽ - American Federation of Government Employees
Need for Collective Bargaining Evident as TSA Again Lands Bottom Spot of Best Places to Work - American Financial Services Association Education Foundation
Emergency Preparations Should Include Finances, Too - American Institute of Certified Public Accountants
AICPA Applauds Introduction of Bill by Representative Boucher and Representative Goodlatte to Prohibit Tax Strategy Patents - More from this issue of Lab Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
